Role Focus:
- Primarily focused on scientific due diligence, data interpretation, evaluation, and strategic advisory support.
- Works closely with internal scientific, clinical, CMC and business teams.
- Evaluates the feasibility, differentiation, and translational potential of next-generation CAR T technology approaches for autoimmune diseases.
Qualifications:
- PhD in Immunology, Biotechnology, Genetic Medicines, or a related field.
- 10+ years of experience in immunology and inflammation (I&I) drug discovery, and cell/gene therapy.
- Deep expertise in CAR T, immune cell engineering, and/or gene delivery technologies.
Additional Details:
- This is a consultant position with West coast hours.
- Duration is 6-12+ months (10-20 hours per week).
- The advisor will partner with internal teams across Research, Translational Science, Clinical, CMC, and Business Development.
Kyverna Therapeutics
Kyverna Therapeutics is a biotechnology company focused on developing CAR T and immune cell engineering therapies for autoimmune diseases. The company fosters a collaborative culture where scientific and business teams work together to evaluate innovative technologies.